Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Puma Biotechnology, Inc. (PBYI) vs REGENXBIO Inc. (RGNX)

Puma Biotechnology, Inc. and REGENXBIO Inc. are both Biotechnology companies. Puma Biotechnology, Inc. and REGENXBIO Inc. are of similar size ($506.9M and $487.8M). REGENXBIO Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.1×. REGENXBIO Inc. grew revenue faster over the last twelve months: 12.0% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −112.6%) and the higher return on invested capital (42.6% vs 0.00%). Across the 17 metrics below, Puma Biotechnology, Inc. leads on 13 and REGENXBIO Inc. on 4.

Valuation

Metric PBYI RGNX Biotechnology median
P/E 18.11 n/m 7.88
P/S 2.15 2.24 11.47
P/B 3.60 5.45 2.52
Price to free cash flow 17.43 n/m 21.16
EV/EBITDA 10.42 n/m 0.74
EV/Sales 1.84 2.12 10.73
Earnings yield 5.52% (51.22%) (28.84%)
Free cash flow yield 5.74% (63.88%) (23.03%)

Profitability

Metric PBYI RGNX Biotechnology median
Gross margin 74.83% 86.38% 65.16%
Operating margin 13.16% (94.08%) 0.00%
Net margin 11.55% (112.58%) 0.00%
Free cash flow margin 17.79% (143.09%) 0.00%
Return on equity 21.97% (137.63%) (57.72%)
Return on assets 13.78% (40.60%) (49.22%)
Return on invested capital 42.61% 0.00% 0.00%

Growth

Metric PBYI RGNX Biotechnology median
Revenue growth (TTM) (2.86%) 12.00% 5.64%
EPS growth (last fiscal year) (1.61%) 18.08% —
Revenue growth, 5-year CAGR 0.29% 1.97% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBYI RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 2.86 4.73
Net debt to EBITDA (1.60) 1.58 0.96

Dividend

Metric PBYI RGNX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PBYI RGNX Biotechnology median
Market cap 506.91m 487.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack